US · MPLT
MapLight Therapeutics, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Redwood City, CA 94063
- Website
- maplightrx.com
Price · as of 2026-07-02
$37.09
Market cap 23.73M
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| MPLT | MapLight Therapeutics, In… | $37.09 | 23.73M | — | — | — | — | — | — | — | — | — |
| BRTX | BioRestorative Therapies,… | $0.48 | 4.31M | — | — | — | +438% | — | — | — | — | — |
| DWTX | Dogwood Therapeutics, Inc… | $1.67 | 3.19M | — | — | — | — | -0.55 | 0.11 | — | -0.61 | — |
| EDSA | Edesa Biotech, Inc. | $7.86 | 69.89M | — | — | — | — | -1.39 | 0.80 | — | 0.11 | — |
| ERNA | Ernexa Therapeutics Inc. | $11.66 | 3.66M | +775% | -85% | — | — | -2.77 | 72.62 | 212.25 | -3.39 | 75588.00% |
| IMRN | Immuron Limited | $1.21 | 7.8M | +1,606% | +11,815% | — | — | -3.14 | 2.04 | 2.25 | -2.00 | 4863.00% |
| LPCN | Lipocine Inc. | $2.26 | 13.12M | — | — | — | +5,426% | — | — | — | — | — |
| OSRH | OSR Holdings, Inc. | $0.46 | 11.3M | — | — | — | +7,506% | — | — | — | — | — |
| PMN | ProMIS Neurosciences, Inc… | $10.87 | 14.21M | — | — | — | — | 7.09 | 1.19 | — | 2.23 | — |
| TRAW | Traws Pharma, Inc. | $1.52 | 13.89M | — | — | +262% | +80,068% | — | — | — | — | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $37.09) − 1 = — (DCF, example).